Laquinimod ameliorates secondary brain inflammation

Laquinimod ameliorates secondary brain inflammation

Accumulating evidence suggests that a degenerative processes within the brain can trigger the formation of new, focal inflammatory lesions in Multiple Sclerosis (MS). Here, we used a novel pre-clinical MS animal model to test whether the amelioration of degenerative brain events reduces the secondar...

Full description

Bibliographic Details
Main Authors: Julia Nedelcu, Christin Reinbach, Philipp Riedler, Matthias Brendel, Axel Rominger, Joel Kaye, Newshan Behrangi, Zhan Jiangshan, Christoph Schmitz, Markus Kipp
Format: Article
Language:English
Published: Elsevier 2020-02-01
Series:Neurobiology of Disease
Subjects:
Cuprizone
Laquinimod
Demyelination
Multiple sclerosis
Online Access:http://www.sciencedirect.com/science/article/pii/S096999611930350X

Internet

http://www.sciencedirect.com/science/article/pii/S096999611930350X

Similar Items